Showing results (21-30 of 914) with videos related to
Sort By:
Pageof 92
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|November 9, 2013
Prescribing of schedule II pain medications in ambulatory medical care settingsL A Rose, B M Devellis, G Howard, et al.Inflammation|September 1, 1977
Treatment of rheumatoid and degenerative diseases with copper complexes: a review with emphasis on copper-salicylateJ R Sorenson, W HangarterCancer|January 10, 2001
Genetic testing for colorectal carcinoma susceptibility: focus group responses of individuals with colorectal carcinoma and first-degree relativesA Y Kinney, B M DeVellis, C Skrzynia, et al.Health Education Quarterly|January 1, 1993
Coping with rheumatoid arthritis: is one problem the same as another?S J Blalock, B M DeVellis, K Holt, et al.Journal of Inorganic Biochemistry|November 1, 1995
Down-regulation of NADPH-diaphorase (nitric oxide synthase) may account for the pharmacological activities of Cu(II)2 (3,5-diisopropylsalicylate)4J G Baquial, J R SorensonBiochemical and Biophysical Research Communications|January 15, 1988
Copper(II)ethylenediaminetetraacetate does disproportionate superoxideW M Willingham, J R SorensonAnticancer Research|March 1, 1989
Evaluation of combinations of CuDIPS, Tween 80 and cyclophosphamide as therapy for reticulum cell sarcoma in SJL/J miceC G Crispens, J R SorensonAnticancer Research|January 1, 1991
Evaluation of the anticancer activities of Tweens 20, 40 and 60 in SJL/J miceC G Crispens, J R SorensonAnticancer Research|January 1, 1988
Evaluation of the anticancer activity of CuDIPS in SJL/J miceC G Crispens, J R SorensonMetal-Based Drugs|May 14, 2008
Calcium(II)(3) (3,5-Diisopropylsalicylate)(6)(H(2)O)(6) Activates Nitric Oxide Synthase: An Accounting for its Action in Decreasing Platelet AggregationD C Donham, J R SorensonPageof 92